Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL INDS | IIIN | 5.28% |
| ERICKSON AIR | EAC | 5.10% |
| ASSURED GUAR | AGO | 4.98% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Full Analysis
Calumet Specialty Products Partners, L.P. is a leading independent producer of high-quality, specialty hydrocarbon products in North America. CLMT processes crude oil into customized lubricating oils, solvents and waxes used in consumer, industrial and automotive products. The company also produces fuel products including gasoline, diesel and jet fuel.
On Aug 7, CLMT reported second-quarter profits of 94 cents per share, compared to 75 cents per share in the prior-year period. In addition to the 25.3% year-over-year improvement, the result equated to a 14.6% positive earnings surprise with analysts calling for 82 cents per share. This marked the second quarter out of the past three in which CLMT beat the Streets estimate. Profits for the first half of the year came in at $65.6 million, compared to $27.4 million for the same period in 2006.
President and CEO Bill Grube stated, "We improved upon our overall performance in the second quarter of 2007 compared to the second quarter of 2006 primarily through increased gross profit in our Fuel Products segment."
Analysts optimism about CLMTs future earnings prospects has been on the rise. The consensus earnings estimate for this year currently sits at $3.48. This marks an 11-cent jump when compared to the consensus of only a week earlier. Two of the three covering analysts upped their projections. Looking ahead to next year, the consensus estimate currently resides at $3.79. It represents a 19-cent increase over the same period of time. An upward revision was submitted by one analyst. Earnings per share are projected to grow 10% over the next 3-5 years.
On Jul 13, the Board of Directors approved an increase to the companys quarterly cash distribution to 63 cents per unit. The dividend will be paid on Aug 14 to shareholders of record as of Aug 4. CLMT has a very impressive current dividend yield of 5.3%. The current increase represents the company's third increase in its quarterly distribution in only its fifth full quarter of operations.
CLMT is currently trading at a valuation of 13.6x current fiscal-year estimated earnings and at 12.5x next fiscal-year estimated earnings. The market, as represented by the S&P 500, is trading at a valuation of 15.5x current fiscal-year estimated earnings and at 14.4x next fiscal-year estimated earnings. The company has a price-to-book ratio of 2.4, compared to 4.6 for the market and 2.9 for the industry.
Get the full Snapshot Report on CLMT - FREE